[podcast] Effectiveness of new drug-resistant TB treatment is maintained with reduction in dosage and duration of Linezolid

Update: 2022-09-11

Description

This podcast features Dr Conor Tweed, Honorary Clinical Lecturer, Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), who is in conversation with CNS founding Managing Editor and Executive Director Shobha Shukla. Jessica Wiggs, Senior Communication Specialist of TB Alliance (Global Alliance of TB Drug Development, www.TBalliance.org) joins the conversation.

Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, Stitcher, TuneIn, aCast, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, Player FM, and other podcast streaming platforms.
Thanks

CNS team

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

[podcast] Reality check on gender justice in Kyrgyzstan: Nurgul Dzhanaeva speaks

2024-09-1511:30

[podcast] Reality check on gender justice in the Pacific: Nalini Singh of Fiji Women's Rights Movements speaks

2024-09-1413:16

[podcast] Asia Pacific not on track to end AIDS, viral hepatitis and sexually transmitted infections

2024-08-2832:00

[podcast] 2024 Asia Pacific Feminist Forum to focus on "Feminist world-building: Creative energies, collective journeys"

2024-08-27--:--

[podcast] Are we focussing on those struggling to access health services with equity & right?

2024-07-1535:21

[podcast] #PutPeopleFirst means walking the talk on "Nothing About Us Without Us"

2024-07-15--:--

[podcast] Finding all people with TB especially those more at risk and linking them to care is key to end TB

2024-07-15--:--

[podcast] AIDS responses must be grounded in human rights

2024-06-2836:03

[podcast] Perspectives of people living with HIV must be central to AIDS response

2024-06-28--:--

[podcast] AMR Dialogues | Dr Sangeeta Sharma speaks on diagnostic stewardship and Antimicrobial Resistance

2024-06-2301:08:47

[podcast] AMR Dialogues | Bhakti Chavan, a member of WHO Task Force of AMR Survivors

2024-06-23--:--

[podcast] Decentralise people-centred services to find all, treat all and prevent all TB among people living with HIV

2024-06-20--:--

[podcast] Are we on track to end malaria by 2030?

2024-06-07--:--

[podcast] WHO Director for HIV, Hepatitis and STIs Dr Meg Doherty in conversation with CNS

2024-05-2344:32

[podcast] Finding TB is central to ending TB: Prof Kogie Naidoo of CAPRISA

2024-05-0134:07

[podcast] Dr Bornali Datta shares high impact journey of Medanta vans reaching the unreached with TB services

2024-04-2331:02

[podcast] TB diagnosis and treatment is free but people face unacceptable catastrophic costs, diagnostic delays

2024-04-0732:27

[podcast] TB science simplified

2024-03-3101:12:07

[podcast] Find all TB → treat all TB → prevent all TB → End TB | Shobha Shukla speaks

2024-03-3113:01

[podcast] Science has gifted us tools to find, treat and prevent TB but are we using them?

2024-03-0812:29

00:00

1.0x

[podcast] Effectiveness of new drug-resistant TB treatment is maintained with reduction in dosage and duration of Linezolid

#box-pro-ellipsis-173501013047327{-webkit-line-clamp:2;}[podcast] Effectiveness of new drug-resistant TB treatment is maintained with reduction in dosage and duration of Linezolid

[podcast] Effectiveness of new drug-resistant TB treatment is maintained with reduction in dosage and duration of Linezolid

CNS www.citizen-news.org

[podcast] Effectiveness of new drug-resistant TB treatment is maintained with reduction in dosage and duration of Linezolid